Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pmid27998201-compound-5 cathepsin b NA Preclinical target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Gastrointestinal Diseases[MeSHID:D005767]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Psoriasis[MeSHID:D011565]
Multiple Sclerosis[MeSHID:D009103]
Liver Cirrhosis[MeSHID:D008103]
Cirrhosis[MeSHID:D005355]		 NA patented unknown
pmid27998201-compound-5 cathepsin f NA Patented-recorded target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Gastrointestinal Diseases[MeSHID:D005767]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Psoriasis[MeSHID:D011565]
Multiple Sclerosis[MeSHID:D009103]
Liver Cirrhosis[MeSHID:D008103]
Cirrhosis[MeSHID:D005355]		 NA patented unknown
pmid27998201-compound-5 cathepsin k NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Gastrointestinal Diseases[MeSHID:D005767]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Psoriasis[MeSHID:D011565]
Multiple Sclerosis[MeSHID:D009103]
Liver Cirrhosis[MeSHID:D008103]
Cirrhosis[MeSHID:D005355]		 NA patented unknown
pmid27998201-compound-5 cathepsin l NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Gastrointestinal Diseases[MeSHID:D005767]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Psoriasis[MeSHID:D011565]
Multiple Sclerosis[MeSHID:D009103]
Liver Cirrhosis[MeSHID:D008103]
Cirrhosis[MeSHID:D005355]		 NA patented unknown
pmid27998201-compound-5 cathepsin s NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Gastrointestinal Diseases[MeSHID:D005767]
Chronic Obstructive Airway Disease[MeSHID:D029424]
Psoriasis[MeSHID:D011565]
Multiple Sclerosis[MeSHID:D009103]
Liver Cirrhosis[MeSHID:D008103]
Cirrhosis[MeSHID:D005355]		 NA patented unknown
click here to return to the previous page